Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Roum Arch Microbiol Immunol ; 71(2): 100-3, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23210324

RESUMEN

Between 2007-2008, epidemic episodes of aseptic meningitis occurred in Romania. Most important strains isolated were Echoviruses. A commercial kit for rapid molecular detection of aetiological agents of aseptic meningitis was tested. The introduction of the molecular tests in clinical use is important by the efficient decision-making concerning the treatment.


Asunto(s)
Meningitis Aséptica/diagnóstico , Juego de Reactivos para Diagnóstico , Adolescente , Adulto , Niño , Preescolar , Enterovirus Humano B/genética , Enterovirus Humano B/aislamiento & purificación , Humanos , Meningitis Aséptica/tratamiento farmacológico , ARN Viral/líquido cefalorraquídeo
2.
Neuromuscul Disord ; 27(10): 911-913, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28802771

RESUMEN

Duchenne Muscular Dystrophy (DMD) is the most frequent muscular dystrophy in childhood, with a worldwide incidence of one in 5000 live male births. It is due to mutations in the dystrophin gene leading to absence of full-length dystrophin protein. Central nervous system involvement is well-known in Duchenne Muscular Dystrophy. The multiple dystrophin isoforms expressed in brain have important roles in cerebral development and functioning. The association of Duchenne Muscular Dystrophy with seizures has been reported, and there is a higher prevalence of epilepsy in Duchenne Muscular Dystrophy patients (between 6.3% and 12.3%) than in the general pediatric population (0.5-1%). Duchenne Muscular Dystrophy patients may present with focal seizures, generalized tonic-clonic seizures or absences. We report on two boys in whom Duchenne Muscular Dystrophy is associated with epileptic spasms and hypsarrhythmia that fulfil the criteria for West syndrome, thus extending the spectrum of seizure types described in Duchenne Muscular Dystrophy patients.


Asunto(s)
Distrofina/genética , Distrofia Muscular de Duchenne/genética , Mutación/genética , Sistema Nervioso Central/metabolismo , Preescolar , Epilepsia/complicaciones , Epilepsia/etiología , Epilepsia/genética , Humanos , Lactante , Masculino , Distrofia Muscular de Duchenne/complicaciones , Isoformas de Proteínas/genética , Convulsiones/etiología , Convulsiones/genética , Espasmos Infantiles/complicaciones , Espasmos Infantiles/genética
3.
JIMD Rep ; 29: 109-113, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26920903

RESUMEN

The C10orf2 gene encodes Twinkle, a protein involved in mitochondrial DNA (mtDNA) replication. Twinkle mutations cause mtDNA deletion or depletion and are associated with a large spectrum of clinical symptoms including dominant progressive external ophthalmoplegia (adPEO), infantile-onset spinocerebellar ataxia (IOSCA), and early-onset encephalopathy. The diagnosis remains difficult because of the wide range of symptoms and lack of association with specific metabolic changes. We report herein a child with early-onset encephalopathy, unusual abnormal movements, deafness, and axonal neuropathy. All laboratory investigations were normal with the exceptions of high alpha-fetoprotein levels and an abnormal glycosylation profile. These abnormal parameters resulted in misdiagnosis as a previously unidentified congenital disorder of glycosylation (CDG) type I syndrome. Whole exome sequencing revealed two point mutations in C10orf2 that were confirmed by Sanger sequencing; neither had been previously reported. This report enlarges the clinical phenotype of Twinkle mutations and suggests that an abnormal glycosylation profile suggestive of CDG type I associated with high blood alpha-fetoprotein levels without obvious cause should prompt Twinkle sequencing.

4.
Neurology ; 86(11): 1022-30, 2016 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-26888987

RESUMEN

OBJECTIVE: To explore the value of nuclear magnetic resonance (NMR) and functional assessments for follow-up of ambulatory and nonambulatory patients with Duchenne muscular dystrophy (DMD). METHODS: Twenty-five 53-skippable patients with DMD were included in this study; 15 were nonambulatory at baseline. All patients underwent clinical and functional assessments every 6 months using the Motor Function Measure (MFM), hand grip and key pinch strength, MoviPlate, and NMR spectroscopy and imaging studies. RESULTS: Upper limb distal strength decreased in nonambulatory patients over the period of 1 year; ambulatory patients showed improvement during the same period. The same applied for several NMRS indices, such as phosphocreatine/adenosine triphosphate, which decreased in older patients but increased in younger ambulatory patients. Fat infiltration in the upper limbs increased linearly with age. Almost all NMR and functional assessment results correlated. CONCLUSIONS: Our results underscore complementarity of functional and NMR assessments in patients with DMD. Sensitivity to change of various indices may differ according to disease stage.


Asunto(s)
Espectroscopía de Resonancia Magnética , Distrofia Muscular de Duchenne/diagnóstico , Distrofia Muscular de Duchenne/fisiopatología , Extremidad Superior/patología , Adolescente , Niño , Estudios de Seguimiento , Humanos , Estudios Longitudinales , Espectroscopía de Resonancia Magnética/métodos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA